WO2000068181A3 - Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof - Google Patents

Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof Download PDF

Info

Publication number
WO2000068181A3
WO2000068181A3 PCT/HU2000/000043 HU0000043W WO0068181A3 WO 2000068181 A3 WO2000068181 A3 WO 2000068181A3 HU 0000043 W HU0000043 W HU 0000043W WO 0068181 A3 WO0068181 A3 WO 0068181A3
Authority
WO
WIPO (PCT)
Prior art keywords
bicyclo
heptane
dimethylamino
ethoxy
tri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/HU2000/000043
Other languages
French (fr)
Other versions
WO2000068181A2 (en
Inventor
Gyula Lukacs
Gyula Simig
Tibor Mezei
Zoltan Budai
Marta Porcs-Makkay
Gyoergy Krasznai
Kalman Nagy
Donath Gyoergyi Vereczkeyne
Tibor Szabo
Norbert Nemeth
Janos Szylagyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL14642100A priority Critical patent/IL146421A0/en
Priority to SI200030989T priority patent/SI1177166T1/en
Priority to MXPA01011420A priority patent/MXPA01011420A/en
Priority to EEP200100595A priority patent/EE04638B1/en
Priority to EP00927613A priority patent/EP1177166B1/en
Priority to BR0010412-4A priority patent/BR0010412A/en
Priority to SK1624-2001A priority patent/SK285780B6/en
Priority to NZ515917A priority patent/NZ515917A/en
Priority to DE60038112T priority patent/DE60038112T8/en
Priority to DK00927613T priority patent/DK1177166T3/en
Priority to CA002373193A priority patent/CA2373193A1/en
Priority to AU46003/00A priority patent/AU776696B2/en
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to JP2000617162A priority patent/JP4031203B2/en
Publication of WO2000068181A2 publication Critical patent/WO2000068181A2/en
Publication of WO2000068181A3 publication Critical patent/WO2000068181A3/en
Priority to NO20015352A priority patent/NO321487B1/en
Priority to IS6152A priority patent/IS6152A/en
Priority to IL146421A priority patent/IL146421A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a process for preparing (1R,2S,4R) -(-)-2-[(2'- {N,N-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof with higher yields and higher grades of purity.
PCT/HU2000/000043 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof Ceased WO2000068181A2 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CA002373193A CA2373193A1 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid additionsalts thereof
MXPA01011420A MXPA01011420A (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof.
EEP200100595A EE04638B1 (en) 1999-05-11 2000-05-10 Method (1R, 2S, 4R) - (-) - 2 - [(2 '- {N, N-dimethylamino} ethoxy)] - 2- [phenyl] -1,7,7-tri [methyl] bicyclo [ 2.2.1] heptane and its pharmaceutically acceptable acid addition salts
EP00927613A EP1177166B1 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy) -2- phenyl -1,7,7-tri- methyl -bicyclo 2.2.1 heptane and pharmaceutically acceptable acid addition salts thereof
BR0010412-4A BR0010412A (en) 1999-05-11 2000-05-10 Process for preparing (1r, 2s, 4r) - (-) - 2 - [(2 '- {n, n-dimethylamino} -ethoxy)] -2- [phenyl] -1,7,7-tri [methyl] -bicycle [2.2.1] heptane
SK1624-2001A SK285780B6 (en) 1999-05-11 2000-05-10 Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}- ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
NZ515917A NZ515917A (en) 1999-05-11 2000-05-10 Process for preparing (1R,2S,4R) -(-)-2-[(2'- {N,N- dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] - bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
DE60038112T DE60038112T8 (en) 1999-05-11 2000-05-10 PROCESS FOR PREPARING (1R, 2S, 4R) - (-) - 2 - [(2 '- {N, N-DIMETHYLAMINO} -ETHOXY)] - 2- [PHENYL] -1,7,7-TRI- [ METHYL] -BICYCLO [2.2.1] HEPTAN AND ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITIONAL SALTS
DK00927613T DK1177166T3 (en) 1999-05-11 2000-05-10 Process for the preparation of (1R, 2S, 4R) - (-) - 2 (2'-N, N-dimethylamino-ethoxy) -2-phenyl-1,7,7-trimethylbicyclo-2.2.1- heptane and pharmaceutically acceptable acid addition salts thereof
IL14642100A IL146421A0 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r)-(-)-2-[2'- {n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-thr-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
SI200030989T SI1177166T1 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy) -2- phenyl -1,7,7-tri- methyl -bicyclo 2.2.1 heptane and pharmaceutically acceptable acid addition salts thereof
AU46003/00A AU776696B2 (en) 1999-05-11 2000-05-10 Process for preparing (1R,2S,4R) -(-)-2-((2'- (n,n-dimethylamino) -ethoxy)) -2-(phenyl) -1,7,7-tri- (methyl) -bicyclo (2.2.1) heptane and pharmaceutically acceptable acid addition salts thereof
JP2000617162A JP4031203B2 (en) 1999-05-11 2000-05-10 (1R, 2S, 4R)-(−)-2-[(2 ′-{N, N-dimethylamino} -ethoxy)]-2- [phenyl] -1,7,7-tri- [methyl]- Process for producing bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
NO20015352A NO321487B1 (en) 1999-05-11 2001-11-01 Process for Preparing (IR, 2S, 4R) - (-) - 2- [2 '- {N, N-Dimethylamino} -ethoxy] -2- [phenyl] -1,7,7-tri [methyl] - biscyclo [2,2,1] heptane and pharmaceutically acceptable addition salts thereof
IS6152A IS6152A (en) 1999-05-11 2001-11-09 Preparation Method (1R, 2S, 4R) - (-) - 2 - [(2 '- {N, N-dimethylamino} -ethoxy)] - 2- [phenyl] -1,7,7-tri- [ methyl] -bicyclo [2.2.1] heptane and its pharmaceutically acceptable acid addition salts
IL146421A IL146421A (en) 1999-05-11 2001-11-11 Process for preparing (1r,2s,4r) - (-) - 2 - [2(2' - {n,n - dimethylamino} - ethoxy)] - 2 - [phenyl1 ] - 1,7,7 - tri - [methyl] - bicyclo [2.2.1] heptane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP9901559 1999-05-11
HU9901559A HU227114B1 (en) 1999-05-11 1999-05-11 (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Publications (2)

Publication Number Publication Date
WO2000068181A2 WO2000068181A2 (en) 2000-11-16
WO2000068181A3 true WO2000068181A3 (en) 2001-06-28

Family

ID=89998272

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/HU2000/000043 Ceased WO2000068181A2 (en) 1999-05-11 2000-05-10 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
PCT/HU2000/000044 Ceased WO2000068183A2 (en) 1999-05-11 2000-05-10 High purity (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/HU2000/000044 Ceased WO2000068183A2 (en) 1999-05-11 2000-05-10 High purity (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them

Country Status (37)

Country Link
US (3) US6242386B1 (en)
EP (4) EP1052245B1 (en)
JP (2) JP4031203B2 (en)
KR (3) KR100685071B1 (en)
CN (2) CN1173928C (en)
AR (2) AR020860A1 (en)
AT (4) ATE386714T1 (en)
AU (2) AU777737B2 (en)
BG (2) BG64442B1 (en)
BR (2) BR0010412A (en)
CA (2) CA2369393C (en)
CO (1) CO5170480A1 (en)
CZ (4) CZ20014050A3 (en)
DE (4) DE60006097T2 (en)
DK (4) DK1177166T3 (en)
EA (2) EA002164B1 (en)
EE (2) EE04638B1 (en)
ES (4) ES2203373T3 (en)
FR (2) FR2793489B1 (en)
HR (2) HRP20000290B1 (en)
HU (1) HU227114B1 (en)
IL (4) IL146421A0 (en)
IS (2) IS2570B (en)
LT (2) LT4928B (en)
MX (2) MXPA01011423A (en)
MY (2) MY122508A (en)
NO (2) NO321486B1 (en)
NZ (2) NZ515917A (en)
PL (2) PL202956B1 (en)
PT (4) PT1177166E (en)
SI (4) SI1052243T1 (en)
SK (4) SK285635B6 (en)
TR (2) TR200200148T2 (en)
TW (2) TWI286541B (en)
UA (2) UA61122C2 (en)
WO (2) WO2000068181A2 (en)
ZA (2) ZA200108956B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
RS20060504A (en) * 2004-03-12 2008-09-29 Egis Gyogyszergyar Nyrt., Combination of deramciclane and opoids as analgesics
JP4916680B2 (en) * 2005-06-30 2012-04-18 株式会社半導体エネルギー研究所 Manufacturing method and peeling method of semiconductor device
US20080258121A1 (en) * 2007-04-23 2008-10-23 Hasan Farooq Fire Retardant Composition
EP2501669B1 (en) 2009-11-19 2018-01-24 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Arylated camphenes, processes for their preparation and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065122A (en) * 1979-12-14 1981-06-24 Egyt Gyogyszervegyeszeti Gyar Basic ethers their preparation and pharmaceutical compositions containing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212574B (en) * 1990-09-21 1996-08-29 Egyt Gyogyszervegyeszeti Gyar Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane
HU214588B (en) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. A method for the preparation of a pharmaceutical composition comprising a CCC system inhibiting a bicycloheptane derivative
HU226061B1 (en) 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (en) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Process for the production of (1R,2S,4R)-(-)-N,N-(dimethylaminoethoxy)-2-phenyl-1,7,7-trimethylbicyclo[2.2.1]heptane and its intermediate
HU227114B1 (en) 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065122A (en) * 1979-12-14 1981-06-24 Egyt Gyogyszervegyeszeti Gyar Basic ethers their preparation and pharmaceutical compositions containing the same
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 118, no. 23, 7 June 1993, Columbus, Ohio, US; abstract no. 234291, BUDAI, ZOLTAN ET AL: "Process for producing (1R,2S)-(-)-2-phenyl-[2'- (dimethylamino)ethoxy)-1,7,7-trimethylbicyclo[2.2.1.]heptane" XP002156197 *

Also Published As

Publication number Publication date
PT1177166E (en) 2008-06-02
JP4536265B2 (en) 2010-09-01
UA49974C2 (en) 2002-10-15
EP1052243A2 (en) 2000-11-15
FR2793490A1 (en) 2000-11-17
KR100581489B1 (en) 2006-05-22
SK6892000A3 (en) 2000-12-11
TR200200148T2 (en) 2002-06-21
PL202956B1 (en) 2009-08-31
ATE386714T1 (en) 2008-03-15
CN1353686A (en) 2002-06-12
ES2194643T3 (en) 2003-12-01
BG104417A (en) 2001-03-30
NO321487B1 (en) 2006-05-15
CZ20001722A3 (en) 2000-12-13
ES2302694T3 (en) 2008-08-01
FR2793489B1 (en) 2004-04-02
EE04672B1 (en) 2006-08-15
BG64673B1 (en) 2005-11-30
BR0010406A (en) 2002-02-13
DE60006097T2 (en) 2004-06-17
CZ291329B6 (en) 2003-02-12
LT2001108A (en) 2002-03-25
LT2001109A (en) 2002-03-25
KR20060010874A (en) 2006-02-02
WO2000068183A2 (en) 2000-11-16
NO321486B1 (en) 2006-05-15
CZ20014051A3 (en) 2002-05-15
EA002163B1 (en) 2001-12-24
ZA200108956B (en) 2003-02-17
ZA200108958B (en) 2002-10-30
CA2369393A1 (en) 2000-11-16
EP1052245A2 (en) 2000-11-15
EP1052243A3 (en) 2001-02-28
EE200100596A (en) 2003-02-17
PT1052245E (en) 2003-09-30
IS2570B (en) 2010-01-15
SK16242001A3 (en) 2002-04-04
AR020860A1 (en) 2002-05-29
EE200100595A (en) 2003-02-17
NO20015352L (en) 2002-01-08
KR100685071B1 (en) 2007-02-22
CO5170480A1 (en) 2002-06-27
PT1177167E (en) 2004-03-31
DE60004126D1 (en) 2003-09-04
US20020040164A1 (en) 2002-04-04
NZ515917A (en) 2004-02-27
MY122508A (en) 2006-04-29
EP1177167B1 (en) 2003-10-22
TW528742B (en) 2003-04-21
DE60002117D1 (en) 2003-05-22
LT4927B (en) 2002-07-25
HRP20000290A2 (en) 2005-02-28
KR20010112486A (en) 2001-12-20
AU4600300A (en) 2000-11-21
EA200000411A2 (en) 2000-12-25
HRP20000291A2 (en) 2001-06-30
ATE237579T1 (en) 2003-05-15
SK285635B6 (en) 2007-05-03
CN1353687A (en) 2002-06-12
DE60006097D1 (en) 2003-11-27
TR200200147T2 (en) 2002-06-21
SI1177166T1 (en) 2008-08-31
ES2203373T3 (en) 2004-04-16
HK1031372A1 (en) 2001-06-15
EP1052243B1 (en) 2003-07-30
MXPA01011423A (en) 2002-06-04
ATE252544T1 (en) 2003-11-15
SK16232001A3 (en) 2002-04-04
CA2369393C (en) 2010-07-06
PT1052243E (en) 2003-12-31
JP4031203B2 (en) 2008-01-09
BG64442B1 (en) 2005-02-28
FR2793490B1 (en) 2004-04-23
EP1177166A2 (en) 2002-02-06
US6624201B2 (en) 2003-09-23
DE60038112D1 (en) 2008-04-03
DE60038112T2 (en) 2009-02-12
DE60038112T8 (en) 2009-05-28
AR023900A1 (en) 2002-09-04
EA200000411A3 (en) 2001-02-26
CA2373193A1 (en) 2000-11-16
EA200000410A2 (en) 2000-12-25
NO20015336L (en) 2002-01-08
EA002164B1 (en) 2001-12-24
IS6153A (en) 2001-11-09
MXPA01011420A (en) 2002-06-04
CZ290734B6 (en) 2002-10-16
IS6152A (en) 2001-11-09
SI1052245T1 (en) 2003-10-31
NO20015336D0 (en) 2001-10-31
AU4773100A (en) 2000-11-21
HK1031220A1 (en) 2001-06-08
DK1052243T3 (en) 2003-11-24
HUP9901559A2 (en) 2002-01-28
US6242386B1 (en) 2001-06-05
DK1177167T3 (en) 2004-03-01
EP1177167A2 (en) 2002-02-06
ES2208328T3 (en) 2004-06-16
FR2793489A1 (en) 2000-11-17
TWI286541B (en) 2007-09-11
DE60002117T2 (en) 2003-12-24
AU776696B2 (en) 2004-09-16
US6335469B1 (en) 2002-01-01
HU9901559D0 (en) 1999-07-28
SK6902000A3 (en) 2000-12-11
MY123523A (en) 2006-05-31
IL146421A (en) 2008-11-26
PL340107A1 (en) 2000-11-20
BR0010412A (en) 2002-02-13
IL146420A0 (en) 2002-07-25
HRP20000291B1 (en) 2005-06-30
AU777737B2 (en) 2004-10-28
CZ20014050A3 (en) 2002-05-15
UA61122C2 (en) 2003-11-17
ATE246170T1 (en) 2003-08-15
HRP20000290B1 (en) 2007-08-31
HU227114B1 (en) 2010-07-28
EP1052245A3 (en) 2001-02-28
SI1177167T1 (en) 2004-04-30
NO20015352D0 (en) 2001-11-01
LT4928B (en) 2002-07-25
EE04638B1 (en) 2006-06-15
SK285780B6 (en) 2007-08-02
IL146421A0 (en) 2002-07-25
DE60004126T2 (en) 2004-04-22
IL146420A (en) 2007-06-03
BG104416A (en) 2001-03-30
SI1052243T1 (en) 2004-02-29
DK1177166T3 (en) 2008-06-16
EA200000410A3 (en) 2001-02-26
WO2000068183A3 (en) 2001-07-26
WO2000068181A2 (en) 2000-11-16
CN1173928C (en) 2004-11-03
CZ20001723A3 (en) 2000-12-13
JP2002544184A (en) 2002-12-24
NZ515918A (en) 2004-02-27
KR20020010914A (en) 2002-02-06
PL340108A1 (en) 2000-11-20
EP1052245B1 (en) 2003-04-16
CN1325465C (en) 2007-07-11
DK1052245T3 (en) 2003-08-11
JP2002544185A (en) 2002-12-24
EP1177166B1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
EP1052243A3 (en) Process for preparing (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof
WO2000071108A3 (en) Methods for treatment of asthma using s-oxybutynin
CA2431400A1 (en) Process for preparing isomers of salbutamol
WO2000046210A3 (en) New process for preparing pesticidal intermediates
WO2001035900A3 (en) Synthesis of 3-ethoxy-4-ethoxycarbonyl phenyl acetic acid, a key acid synthon of repaglinide
CA2156764A1 (en) Process for the preparation of the (-)-n-methyl-n-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]benzamine and its pharmaceutically acceptable salts
AU2001236266A1 (en) Use of a compound for preparing a drug
WO2000063175A3 (en) Novel process
CA2297124A1 (en) Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00808239.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001/08958

Country of ref document: ZA

Ref document number: 200108958

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/01019/DE

Country of ref document: IN

ENP Entry into the national phase

Country of ref document: CA

Ref document number: 2373193

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2000 617162

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001108

Country of ref document: LT

Ref document number: 16242001

Country of ref document: SK

Ref document number: 2000927613

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 46003/00

Country of ref document: AU

Ref document number: PA/a/2001/011420

Country of ref document: MX

Ref document number: PV2001-4050

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 1020017014354

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 515917

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2002/00148

Country of ref document: TR

WWP Wipo information: published in national office

Ref document number: 1020017014354

Country of ref document: KR

Ref document number: 2000927613

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001108

Country of ref document: LT

WWP Wipo information: published in national office

Ref document number: PV2001-4050

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 2001108

Country of ref document: LT

WWR Wipo information: refused in national office

Ref document number: PV2001-4050

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 46003/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1020017014354

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 2000927613

Country of ref document: EP